Mankind Pharma, India’s fourth-largest drugmaker by domestic sales, has launched a qualified institutional placement (QIP) to raise up to Rs 3,000 crore, with the funds earmarked to partly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback